Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze SBLOF stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate SBLOF investment potential.

What is SBLOF stock price today?

Get real-time SBLOF stock price, historical data, and price charts on Financhill. Track SBLOF performance with our advanced analysis tools.

Is SBLOF a good investment?

Evaluate SBLOF investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy SBLOF stock?

To buy SBLOF stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of SBLOF?

View detailed market capitalization data and company valuation metrics for SBLOF on our comprehensive analysis page.

What is the P/E ratio of SBLOF?

Use our fundamental analysis tools to view SBLOF P/E ratio and compare valuation metrics with industry peers.

What are SBLOF earnings?

View SBLOF earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Shin Nippon Biomedical Laboratories, Ltd. 10K Form

Buy

SBLOF
Shin Nippon Biomedical Laboratories, Ltd.

Last Price:

$9.36

Seasonality Move:

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SBLOF News And Ratings

See the #1 stock for the next 7 days that we like better than SBLOF

SBLOF Financial Statistics

Sales & Book Value

Annual Sales:	$212.6M
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$6.16
Price / Book:	1.63

Profitability

EPS (TTM):	0.74020
Net Income (TTM):	$30.4M
Gross Margin:	$108.7M
Return on Equity:	11.53%
Return on Assets:	4.91%

Shin Nippon Biomedical Laboratories, Ltd. Earnings Forecast

Key Shin Nippon Biomedical Laboratories, Ltd. Financial Ratios

The Gross Profit Margin over the past 21 years for SBLOF is 51.12%.
The Selling, General & Administrative Expenses for SBLOF have been equal to 43.12% of Gross Profit Margin.
The Research & Development expenses have been 6.84% of Revenue.
The Interest Expense is 4.17% of Operating Income.
The Net Earning history of SBLOF is 15.01% of Total Revenues.
Per Share Earnings over the last 21 years have been positive in 11 years.

Shin Nippon Biomedical Laboratories, Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Life Sciences Tools & Services
Sector:	Health Care
Current Symbol:	SBLOF
Website:	snbl.co.jp

Debt

Debt-to-Equity Ratio:	1.01
Current Ratio:	1.1
Quick Ratio:	0.62

Price-to-Earnings

Trailing P/E Ratio:	12.93
Forward P/E Ratio:	0

SBLOF Technical Analysis vs Fundamental Analysis

Buy

Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) is a Buy

Is Shin Nippon Biomedical Laboratories, Ltd. a Buy or a Sell?

Shin Nippon Biomedical Laboratories, Ltd. stock is rated a Buy

The current Shin Nippon Biomedical Laboratories, Ltd. [SBLOF] share price is $10.03. The Score for SBLOF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.